Research & News

Weiss Investor Signals Subscription Your Issue
Dear Member, Taubman Centers Inc. (TCO, Weiss Ratings B) operates as a real estate investment trust. It owns, manages and leases 22 regional, super-regional and outlet shopping centers in the...
Pivotal Point
While all the focus has been on the Federal Reserve over the past week, and stocks overall have paused for breath, companies like Darden Restaurants (DRI, Weiss Ratings: B) are being rewarded for...
Weiss Investor Signals Subscription Your Issue
Dear Member, Teekay Tankers Ltd. (TNK, Weiss Ratings B+) transports crude oil and refined petroleum products worldwide. As of April 30, 2014, it owned a fleet of 29 double-hull vessels,...
Pivotal Point
Here are a few notes from my research and conversations on tech and markets over the weekend. — Watch out, Tesla. Mercedes is launching its first plug-in hybrid-electric midsize sedan, the...
Weiss Investor Signals Subscription Your Issue
Dear Member, Huntsman Corp. (HUN, Weiss Ratings B) manufactures and sells organic and inorganic chemical products worldwide. The company operates in five segments: Polyurethanes, Performance...
Wealth Megatrends Subscription Your Issue
Guide To Digital Privacy Introduction We’re going to get right to the heart of the matter: This report is about your privacy. Your digital privacy. We’re not going to review all the reasons...
Weiss Investor Signals Subscription Your Issue
Dear Member, Domtar Corp. (UFS, Weiss Ratings B+) designs, manufactures, markets and distributes communications papers, specialty and packaging papers and absorbent hygiene products throughout...
Pivotal Point
It’s a bird, it’s a plane — it’s Super-Dollar, soaring higher into the investment stratosphere and rattling the cages of U.S. multinationals with its sonic booms. The damage is getting...
Weiss Investor Signals Subscription Your Issue
Dear Member, Cintas Corp. (CTAS, Weiss Ratings A+) provides corporate identity uniforms and related business services primarily in North America, Latin America, Europe and Asia. The company’s...
Weiss Investor Signals Subscription Your Issue
Dear Member, SciClone Pharmaceuticals Inc. (SCLN, Weiss Ratings B+) is a specialty pharmaceutical company that provides therapies for the treatment of oncology, infectious diseases and...
Weiss Ratings